Allan Vaag

Active 1990–2025

152
Papers
25,556
Citations
89
h-index
145
i10-index

Citations

Citations per year for Allan Vaag1974: 1 citations1986: 1 citations1991: 1 citations1992: 9 citations1993: 23 citations1994: 20 citations1995: 21 citations1996: 27 citations1997: 28 citations1998: 36 citations1999: 41 citations2000: 41 citations2001: 47 citations2002: 52 citations2003: 68 citations2004: 50 citations2005: 80 citations2006: 130 citations2007: 174 citations2008: 222 citations2009: 243 citations2010: 352 citations2011: 368 citations2012: 407 citations2013: 319 citations2014: 343 citations2015: 338 citations2016: 300 citations2017: 276 citations2018: 243 citations2019: 763 citations2020: 721 citations2021: 688 citations2022: 576 citations2023: 387 citations2024: 591 citations2025: 310 citations2026: 7 citations1975–1985: no citations, so these years are not shown1987–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,564 citing papers, 22.1% of this breakdownUnited Kingdom: 1,054 citing papers, 9.1% of this breakdownChina: 775 citing papers, 6.7% of this breakdownDenmark: 618 citing papers, 5.3% of this breakdownGermany: 582 citing papers, 5% of this breakdownItaly: 477 citing papers, 4.1% of this breakdownAustralia: 465 citing papers, 4% of this breakdownCanada: 448 citing papers, 3.8% of this breakdownSweden: 439 citing papers, 3.8% of this breakdownSpain: 352 citing papers, 3% of this breakdownNetherlands: 335 citing papers, 2.9% of this breakdownFrance: 287 citing papers, 2.5% of this breakdown
0%22.1%Other 27.7%

Fields

  • Medicine55.1%
  • Biochemistry, Genetics and Molecular Biology36.2%
  • Neuroscience2.5%
  • Immunology and Microbiology1.5%
  • Nursing0.9%
  • Psychology0.7%
  • Other3.1%

Topics

  • Epigenetics and DNA Methylation5.9%
  • Birth, Development, and Health4.2%
  • Pancreatic function and diabetes4.1%
  • Diabetes Treatment and Management3.9%
  • Adipose Tissue and Metabolism3.7%
  • Adipokines, Inflammation, and Metabolic Diseases3.1%
  • Other75.1%

Coauthors

All papers

Open in search
  1. Epigenetic differences arise during the lifetime of monozygotic twins

    Authors: , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 3,602

  2. Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

    Authors: , , , , , , , - New England Journal of Medicine 2007 cited by 1,793

  3. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

    Authors: , , , , , , , , , - Diabetologia 2009 cited by 829

  4. Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shane C. Wright, Volker M. Lauschke, Niels Grarup, Alexander S. Hauser, Mette M. Rosenkilde - Nature Metabolism 2024 cited by 42

  5. Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , - JAMA 2017 cited by 251

  6. Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , - Diabetes 2014 cited by 395

  7. Natural History of Insulin Sensitivity and Insulin Secretion in the Progression From Normal Glucose Tolerance to Impaired Fasting Glycemia and Impaired Glucose Tolerance: The Inter99 Study

    Authors: , , , , , - Diabetes Care 2008 cited by 213

  8. TXNIP Regulates Peripheral Glucose Metabolism in Humans

    Authors: , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2007 cited by 497

  9. Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications

    Authors: , , , , , , , - Diabetes Care 2022 cited by 51

  10. Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood

    Authors: , , , , , , , , , , , , , , , , - Human Molecular Genetics 2015 cited by 270

  11. DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk

    Authors: , , , , , , , , , , - Epigenetics 2016 cited by 196

  12. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

    Authors: , , , - Diabetologia 2009 cited by 248

  13. Genetics of diabetes-associated microvascular complications

    Authors: , - Diabetologia 2023 cited by 81

  14. Epigenome-Wide Association Study of Incident Type 2 Diabetes in a British Population: EPIC-Norfolk Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Diabetes 2019 cited by 154

  15. Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study

    Authors: , , , - Diabetologia 1999 cited by 618

  16. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort

    Authors: , , , , , , , , , , , - Journal of Diabetes and its Complications 2017 cited by 148

  17. Dnmt3a is an epigenetic mediator of adipose insulin resistance

    Authors: , , , , , , , , , , , - eLife 2017 cited by 126

  18. Elevated circulating follistatin associates with an increased risk of type 2 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claes B. Wollheim, Gunnar Engström, Jianping Weng, Ewan R. Pearson, Paul W. Franks, Morris F. White, Kevin L. Duffin, Allan Vaag, Markku Laakso, Norbert Stefan, Leif Groop, Yang De Marinis - Nature Communications 2021 cited by 65

  19. Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes

    Authors: , , , , , - Diabetes Care 2009 cited by 414

  20. Genetic variants of gestational diabetes mellitus: a study of 112 SNPs among 8722 women in two independent populations

    Authors: , , , , , , , , , , , , , , , , - Diabetologia 2018 cited by 116

  21. CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 108

  22. Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort

    Authors: , , , , , , , , , , , , , , , , , , - BMJ Open Diabetes Research & Care 2022 cited by 48

  23. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

    Authors: , , , , , , - BMJ 2011 cited by 391

  24. Blood-based biomarkers of age-associated epigenetic changes in human islets associate with insulin secretion and diabetes

    Authors: , , , , , , , , , , , , , , - Nature Communications 2016 cited by 243